AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Davis, JC Totoritis, MC Rosenberg, J Sklenar, TA Wofsy, D
Citation: Jc. Davis et al., Phase I clinical trial of a monoclonal antibody against CD40-Ligand (IDEC-131) in patients with systemic lupus erythematosus, J RHEUMATOL, 28(1), 2001, pp. 95-101

Authors: Wada, T Schwarting, A Chesnutt, MS Wofsy, D Kelley, VR
Citation: T. Wada et al., Nephritogenic cytokines and disease in MRL-Fas(lpr) kidneys are dependent on multiple T-cell subsets, KIDNEY INT, 59(2), 2001, pp. 565-578

Authors: Daikh, DI Wofsy, D
Citation: Di. Daikh et D. Wofsy, Treatment of autoimmunity by inhibition of T cell costimulation, ADV EXP MED, 490, 2001, pp. 113-117

Authors: Daikh, DI Wofsy, D
Citation: Di. Daikh et D. Wofsy, Cutting edge: Reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide, J IMMUNOL, 166(5), 2001, pp. 2913-2916

Authors: Diamond, B Bluestone, J Wofsy, D
Citation: B. Diamond et al., The immune tolerance network and rheumatic disease - Immune tolerance comes to the clinic, ARTH RHEUM, 44(8), 2001, pp. 1730-1735

Authors: Daikh, DI Wofsy, D
Citation: Di. Daikh et D. Wofsy, Effects of anti-B7 monoclonal antibodies on humoral immune responses, J AUTOIMMUN, 12(2), 1999, pp. 101-108

Authors: Jeddi, P Keusch, J Lydyard, PM Bodman-Smith, KB Chesnutt, MS Wofsy, D Hirota, H Taga, T Delves, PJ
Citation: P. Jeddi et al., The effect on immunoglobulin glycosylation of altering in vivo production of immunoglobulin G, IMMUNOLOGY, 98(3), 1999, pp. 475-480

Authors: Daikh, DI Wofsy, D
Citation: Di. Daikh et D. Wofsy, Treatment of systemic lupus erythematosus by selective inhibition of T-cell function, CONT IMMUN, 7, 1999, pp. 642-655

Authors: Daikh, DI Wofsy, D
Citation: Di. Daikh et D. Wofsy, On the horizon: Clinical trials of new immunosuppressive strategies for autoimmune diseases, TRANSPLAN P, 30(8), 1998, pp. 4027-4028
Risultati: 1-9 |